GP-Act III Acquisition Common Stock

GP-Act III Acquisition's common stock stands at $200M as of June 2026. That compares with $300M in the prior-year period — down 35.1% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

GP-Act III Acquisition reported $200M in common stock versus $300M a year earlier — a 35.1% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $300M in the prior-year period — down 35.1% year over year. Sustained growth in common stock can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how GP-Act III Acquisition's common stock evolved across reporting periods, while the comparison chart places GPAT next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.